Meet the editors

Dr. Rajeev K. Tyagi obtained a Ph.D. from the Biomedical Parasitology Unit, Institute Pasteur, France, in 2011 with a study on malaria immunology/parasitology. He developed a long-lasting, stable, and straightforward laboratory animal model to study the biology and immunology of infectious diseases and more. Dr. Tyagi continued to work on parasite immunology and mouse–human chimeras development at the University of

South Florida, USA, and explored the asexual blood and liver stage infection of *P. falciparum*. Dr. Tyagi discovered a novel dendritic-like cell population called "pathogen differentiated dendritic cells (PDDCs)" when incubated with *P. gingivalis* and tracking of monocyte-derived dendritic cells (MoDcs) in a reconstituted immunodeficient NOD.*PrkdcscidIl2rg-/-* (NSG) mice at Augusta University, USA. Dr. Tyagi explored IL-23R in the modulation of the functioning of regulatory T cells and its role in the pathogenesis of colitis in an experimental humanized mouse at Vanderbilt University Medical Centre (VUMC), USA. Currently, Dr. Tyagi leads a research group at CSIR-Institute of Microbial Technology, India.

Prakriti Sharma obtained an MSc in Biotechnology from HNB Gharwal University, India, in 2013. He studied the characterization and diversity of plant growth-promoting rhizobacteria from maize. Dr. Sharma obtained a Ph.D. in Biotechnology from Guru Angad Dev Veterinary and Animal Sciences University, India, in 2022 with in vivo studies on the role of nuclear factor of activated T-cell (NFAT) signaling pathway in lung damage

following exposure to deltamethrin insecticide.

Dr. Praveen Sharma obtained a Ph.D. from the Laboratory of Molecular Medicine, Central University of Punjab, India, in 2021 with a study on the regulation of mitochondrial metabolism mediated by small regulatory molecules. Dr. Sharma works on developing a further understanding of the molecular aspects of breast cancer pathology. Additionally, Dr. Sharma has worked in collaboration with pharmacological laboratories to

investigate the anti-cancer effects of different synthesized molecules and various natural extracts.
